Ligand Pharmaceuticals reported $1.08B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
Agenus AGEN:US $ 456.17M 14.87M
Amgen AMGN:US $ 59294M 98M
Anika Therapeutics ANIK:US $ 354.12M 11.88M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Baxter International BAX:US $ 31831M 885M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Clovis Oncology CLVS:US $ 392.86M 58.67M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Enanta Pharmaceuticals ENTA:US $ 385.21M 21.6M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 8904500M 64400M
Glaxosmithkline GSK:US $ 89045M 644M
Harsco HSC:US $ 2798.96M 252.5M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Immunogen IMGN:US $ 422.3M 59.41M
Insmed INSM:US $ 1.05B 99.96M
Intrexon XON:US $ 321.22M 14.34M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Lannett LCI:US $ 484.44M 87.87M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Macrogenics MGNX:US $ 218.04M 53.4M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Spectrum Pharmaceuticals SPPI:US $ 79.43M 20.62M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
Veracyte VCYT:US $ 1144.2M 29.39M